Shila Mekhoubad, Ph.D. - Publications
Affiliations: | 2011 | Harvard University, Cambridge, MA, United States |
Area:
Stem Cell, Neurodegenerative diseasesYear | Citation | Score | |||
---|---|---|---|---|---|
2017 | Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, Kashin S, Mekhoubad S, Ilic D, Charlton M, Saphier G, Handsaker RE, Genovese G, Bar S, Benvenisty N, et al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. PMID 28445466 DOI: 10.1038/Nature22312 | 0.492 | |||
2014 | Smith ZD, Chan MM, Humm KC, Karnik R, Mekhoubad S, Regev A, Eggan K, Meissner A. DNA methylation dynamics of the human preimplantation embryo. Nature. 511: 611-5. PMID 25079558 DOI: 10.1038/Nature13581 | 0.467 | |||
2012 | Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell. 10: 595-609. PMID 22560080 DOI: 10.1016/J.Stem.2012.02.014 | 0.368 | |||
2008 | Silva SS, Rowntree RK, Mekhoubad S, Lee JT. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 105: 4820-5. PMID 18339803 DOI: 10.1073/Pnas.0712136105 | 0.521 | |||
Show low-probability matches. |